Macrophages protect mycoplasma-infected chronic myeloid leukemia cells from natural killer cell killing

Immunol Cell Biol. 2020 Feb;98(2):138-151. doi: 10.1111/imcb.12309. Epub 2020 Jan 13.

Abstract

Macrophages (Mϕ) have been reported to downmodulate the cytotoxicity of natural killer (NK) cell against solid tumor cells. However, the collaborative role between NK cells and Mϕ remains underappreciated, especially in hematological cancers, such as chronic myeloid leukemia (CML). We observed a higher ratio of innate immune cells (Mϕ and NK) to adaptive immune cells (T and B cells) in CML bone marrow aspirates, prompting us to investigate the roles of NK and Mϕ in CML. Using coculture models simulating the tumor inflammatory environment, we observed that Mϕ protects CML from NK attack only when CML was itself mycoplasma-infected and under chronic infection-inflammation condition. We found that the Mϕ-protective effect on CML was associated with the maintenance of CD16 level on the NK cell membrane. Although the NK membrane CD16 (mCD16) was actively shed in Mϕ + NK + CML trioculture, the NK mCD16 level was maintained, and this was independent of the modulation of sheddase by tissue inhibitor of metalloproteinase 1 or inhibitory cytokine transforming growth factor beta. Instead, we found that this process of NK mCD16 maintenance was conferred by Mϕ in a contact-dependent manner. We propose a new perspective on anti-CML strategy through abrogating Mϕ-mediated retention of NK surface CD16.

Keywords: Chronic infection; chronic myeloid leukemia; inflammation; macrophages; maintenance of NK mCD16; natural killer cells; tumor environment.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adaptive Immunity
  • B-Lymphocytes / immunology
  • Cell Differentiation / immunology
  • Cell Line, Tumor
  • Cell Survival / immunology
  • Coculture Techniques
  • Cytokines / metabolism
  • Cytotoxicity, Immunologic
  • GPI-Linked Proteins / immunology
  • GPI-Linked Proteins / metabolism
  • Humans
  • Inflammation / immunology*
  • Interleukin-8 / metabolism
  • Killer Cells, Natural / immunology*
  • Killer Cells, Natural / metabolism
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / enzymology
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / immunology*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / metabolism
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / microbiology
  • Macrophages / immunology*
  • Macrophages / microbiology
  • Mycoplasma / immunology*
  • Receptors, IgG / immunology
  • Receptors, IgG / metabolism
  • Tissue Inhibitor of Metalloproteinase-1 / pharmacology
  • Transforming Growth Factor beta / metabolism

Substances

  • Cytokines
  • FCGR3B protein, human
  • GPI-Linked Proteins
  • Interleukin-8
  • Receptors, IgG
  • Tissue Inhibitor of Metalloproteinase-1
  • Transforming Growth Factor beta